Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPRESS-AF: Spironolactone in AF with Preserved Ejection Fraction
NCT02673463Phase 4Unknown
- Sponsor
- University of Birmingham
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in Atrial fibrillation (AFib), sponsored by University of Birmingham. Status: unknown.
02
Drugs
spironolactone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02673463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673463.